Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

GSK

Gsk (GSK)

Gsk Plc
De:
Trier par:
 Showing the most relevant articles for your search:LSE:GSK
DateHeureSourceTitreSymboleSociété
03/05/202416h30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
01/05/202416h00RNS Regulatory NewsGSK PLC Total Voting RightsLSE:GSKGsk Plc
01/05/202409h50Alliance NewsAlliance NewsTOP NEWS: GSK expects momentum to continue after strong first quarterLSE:GSKGsk Plc
01/05/202408h00RNS Regulatory NewsGSK PLC 1st Quarter ResultsLSE:GSKGsk Plc
24/04/202410h14Alliance NewsAlliance NewsGSK's Jemperli with chemotherapy accepted for priority review by FDALSE:GSKGsk Plc
24/04/202408h00RNS Regulatory NewsGSK PLC US FDA accepts new indication filing for JemperliLSE:GSKGsk Plc
17/04/202409h46Alliance NewsAlliance NewsTOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatmentLSE:GSKGsk Plc
17/04/202408h05RNS Regulatory NewsGSK PLC GSK announces additional EAGLE-1 resultsLSE:GSKGsk Plc
17/04/202408h00RNS Regulatory NewsGSK PLC Results from long-term data relating to ShingrixLSE:GSKGsk Plc
16/04/202415h11RNS Regulatory NewsGSK PLC Amendment - Director/PDMR ShareholdingLSE:GSKGsk Plc
16/04/202409h59Alliance NewsAlliance NewsGSK's latest meningitis vaccine accepted for review by US regulatorLSE:GSKGsk Plc
16/04/202408h00RNS Regulatory NewsGSK PLC FDA accepts GSK meningitis vaccine candidate fileLSE:GSKGsk Plc
08/04/202411h27Alliance NewsAlliance NewsIN THE KNOW: Barclays ups GSK price target but HIV drug nerves remainLSE:GSKGsk Plc
04/04/202413h05RNS Regulatory NewsGSK PLC Replacement - Total Voting RightsLSE:GSKGsk Plc
25/03/202414h00RNS Regulatory NewsGSK PLC Notice of AGMLSE:GSKGsk Plc
22/03/202417h20RNS Regulatory NewsGSK PLC Transfer of Treasury SharesLSE:GSKGsk Plc
18/03/202410h30RNS Regulatory NewsGSK PLC New Phase III Jemperli data in endometrial cancerLSE:GSKGsk Plc
18/03/202409h47Alliance NewsAlliance NewsGSK says Jemperli combination gets good results for endometrial cancerLSE:GSKGsk Plc
08/03/202418h12RNS Regulatory NewsGSK PLC Board Committee ChangeLSE:GSKGsk Plc
07/03/202410h38Alliance NewsAlliance NewsGSK observes positive data in Blenrep trial for blood cancer treatmentLSE:GSKGsk Plc
07/03/202408h00RNS Regulatory NewsGSK PLC GSK announces positive Blenrep DREAMM-8 resultsLSE:GSKGsk Plc
06/03/202417h00RNS Regulatory NewsGSK PLC ViiV LAI vs oral SOC data in adherence-challengedLSE:GSKGsk Plc
05/03/202418h24RNS Regulatory NewsGSK PLC GSK Annual Report 2023 on Form 20-FLSE:GSKGsk Plc
05/03/202412h03Alliance NewsAlliance NewsGSK says ViiV's cabotegravir study supports longer HIV dose intervalLSE:GSKGsk Plc
05/03/202408h00RNS Regulatory NewsGSK PLC New ViiV LA formulation potential 4-month dosingLSE:GSKGsk Plc
01/03/202413h15RNS Regulatory NewsGSK PLC GSK publishes Annual Report 2023LSE:GSKGsk Plc
29/02/202410h44Alliance NewsAlliance NewsTOP NEWS: GSK avoids "protracted litigation" with Zantac settlementLSE:GSKGsk Plc
29/02/202408h05RNS Regulatory NewsGSK PLC Directorate ChangeLSE:GSKGsk Plc
29/02/202408h00RNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
26/02/202409h25Alliance NewsAlliance NewsGSK gonorrhoea treatment achieves efficacy endpoint in latest trialLSE:GSKGsk Plc
 Showing the most relevant articles for your search:LSE:GSK